drug

apraclonidine

1 story · latest Oct 16, 2026

Follow apraclonidine. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: FDA approved Dec 1987 · NDA019779, NDA020258
Brands: Iopidine, Iopidine 1%

Relationships

Developed by Sandoz

Developed by Harrow Inc

Also known as

apraclonidine hydrochloride ophthalmic solution

Timeline

FDA approves Alcon's BRYTLY, a new apraclonidine eye drop formulation

Oct 16Regulatory decisionapraclonidine

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.